eTheRNA immunotherapies conference attendance from September to October 2021

22 September 2021 | Wednesday | News


eTheRNA immunotherapies NV (‘eTheRNA’), a private clinical-stage biotechnology company developing mRNA-based immunotherapies for the treatment of cancer and infectious diseases, will be attending the following conferences from September through to October 2021:

FlandersBio - Knowledge for Growth

27–29 September 2021

Michael Mulqueen, VP of Business Development, will be speaking as part of the ‘The Power of Cell & Gene- Personalised Medicine’ panel on Tuesday, 28 September from 11:00am-12:00pm CET.

Tim Van Assche, Director of Business Development and Alliance Management, and Johanna Madero, Communications Coordinator, will be in attendance.

Optimum Healthcare Investor Conference

4 October 2021

Mathieu Lane, Chief Financial Officer, and President of eTheRNA Inc., will be in attendance.

AACR Virtual Conference on Tumour Immunology and Immunotherapy

5-6 October, 2021

Anna Kuchmiy, Discovery Scientist, will be in attendance.

Access Biotech China

14-15 October 2021

Steven Powell, Chief Executive Officer, will be speaking as part of the ‘Partnering with Chinese Companies and/or Investors’ panel, on Thursday, 14 October from 9:00am-10:30am CET.

Bio-Europe

25-28 October 2021

Michael Mulqueen, VP of Business Development, and Tim Van Assche, Director of Business Development and Alliance Management, will be in attendance.

Biologics Contract Manufacturing Europe

27-28 October 2021

Bernard Sagaert, COO and SVP of Manufacturing, will be speaking as part of the ‘GMP Manufacturing Requirements and Processes’ panel on Thursday, 28 October 2021 from 9:00am-9:30am CET.

David Ricketts, Director of Business Development, will be in attendance.

Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close